Memphasys Signs Three-Year Exclusive Distribution Agreement for Sperm Separation System Covering Czech Republic, Slovakia, Kazakhstan

MT Newswires Live
3 hours ago

Memphasys (ASX:MEM) signed a three-year exclusive distribution agreement for the Felix sperm separation system with specialist IVF supplier INVIDO LAB covering the Czech Republic, Slovakia, and Kazakhstan, according to a Friday Australian bourse filing.

The agreement adds 416,200 euros in minimum contracted purchases over the initial three-year term, with annual minimums increasing from around AU$139,000 in the first year to around AU$310,000 in the third year as adoption increases.

INVIDO has exclusivity across the three countries for Felix cartridges and consoles, subject to agreed minimum purchase and other commercial performance requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10